Psychiatry Research
Volume 135, Issue 3 , Pages 171-177 , 30 June 2005

No association between common variations in the neuronal nicotinic acetylcholine receptor alpha2 subunit gene (CHRNA2) and bipolar I disorder

Received 19 August 2004 ,Revised 14 February 2005 ,Accepted 12 April 2005.

References 

  1. Araki H, Suemaru K, Gomita Y. Neuronal nicotinic receptor and psychiatric disorders: functional and behavioral effects of nicotine. Japanese Journal of Pharmacology. 2002;88(2):133–138
  2. Blaveri E, Kalsi G, Lawrence J, Quested D, Moorey H, Lamb G, et al. Genetic association studies of schizophrenia using the 8p21–22 genes: prepronociceptin (PNOC), neuronal nicotinic cholinergic receptor alpha polypeptide 2 (CHRNA2) and arylamine N-acetyltransferase 1 (NAT1). European Journal of Human Genetics. 2001;9(6):469–472
  3. Caldarone BJ, Harrist A, Cleary MA, Beech RD, King SL, Picciotto MR. High-affinity nicotinic acetylcholine receptors are required for antidepressant effects of amitriptyline on behavior and hippocampal cell proliferation. Biological Psychiatry. 2004;56:657–664
  4. Cichon S, Schumacher J, Müller DJ, Hurter M, Windemuth C, Strauch K, et al. A genome screen for genes predisposing to bipolar affective disorder detects a new susceptibility locus on 8q. Human Molecular Genetics. 2001;10(25):2933–2944
  5. Craddock N, Jones I. Genetics of bipolar disorder. Journal of Medical Genetics. 1999;36(8):585–594
  6. Dudbridge F. Pedigree disequilibrium tests for multilocus haplotypes. Genetic Epidemiology. 2003;25(2):115–121
  7. Faraone SV, Su J, Taylor L, Wilcox M, Van Eerdewegh P, Tsuang MT. A novel permutation testing method implicates sixteen nicotinic acetylcholine receptor genes as risk factors for smoking in schizophrenia families. Human Hereditary. 2004;57:59–68
  8. Freedman ML, Reich D, Penney KL, McDonald GJ, Mignault AA, Patterson N, et al. Assessing the impact of population stratification on genetic association studies. Nature Genetics. 2004;36(4):388–393
  9. Gauderman WJ. Sample size requirements for association studies of gene–gene interaction. American Journal of Epidemiology. 2002;155(5):478–484
  10. Kennedy N, Boydell J, Kalidindi S, Fearon P, Jones PB, van Os J, et al. Gender differences in incidence and age at onset of mania and bipolar disorder over a 35-year period in Camberwell, England. American Journal of Psychiatry. 2005;162:257–262
  11. Lander ES, Schork NJ. Genetic dissection of complex traits. Science. 1994;265(5181):2037–2048
  12. Lasser K, Boyd JW, Woolhandler S, Himmelstein DU, McCormick D, Bor DH. Smoking and mental illness: a population-based prevalence study. Journal of the American Medical Association. 2000;284(20):2606–2610
  13. Leonard S, Adler LE, Benhammou K, Berger R, Breese CR, Drebing C, et al. Smoking and mental illness. Pharmacology, Biochemistry and Behavior. 2001;70(4):561–570
  14. Leonard S, Gault J, Hopkins J, Logel J, Vianzon R, Short M, et al. Association of promoter variants in the alpha7 nicotinic acetylcholine receptor subunit gene with an inhibitory deficit found in schizophrenia. Archives of General Psychiatry. 2002;59(12):1085–1096
  15. Lewis SJ, Brunner EJ. Methodological problems in genetic association studies of longevity—the apolipoprotein E gene as an example. International Journal of Epidemiology. 2004;33:962–970
  16. Lindstrom JM. Nicotinic acetylcholine receptors of muscles and nerves: comparison of their structures, functional roles, and vulnerability to pathology. Annals of the New York Academy of Sciences. 2003;998:41–52
  17. Lopez-Valdes H, Garcia-Colunga J, Miledi R. Effects of clomipramine on neuronal nicotinic acetylcholine receptors. European Journal of Pharmacology. 2002;444(1–2):13–19
  18. Martin-Ruiz C, Lawrence S, Piggott M, Kuryatov A, Lindstrom J, Gotti C, et al. Nicotinic receptors in the putamen of patients with dementia with Lewy bodies and Parkinson's disease: relation to changes in alpha-synuclein expression. Neuroscience Letters. 2002;335(2):134–138
  19. McEvoy JP, Allen TB. The importance of nicotinic acetylcholine receptors in schizophrenia, bipolar disorder and Tourette's syndrome. Current Drug Targets—CNS and Neurological Disorders. 2002;1(4):433–442
  20. Mihailescu S, Drucker-Colin R. Nicotine, brain nicotinic receptors, and neuropsychiatric disorders. Archives of Medical Research. 2000;31(2):131–144
  21. NIMH Genetics Initiative Bipolar Group. Genomic survey of bipolar illness in the NIMH Genetics Initiative pedigrees: a preliminary report. American Journal of Medical Genetics. 1997;74(3):227–237
  22. Nurnberger JI, Blehar MC, Kaufmann CA, York-Cooler C, Simpson SG, Harkavy-Friedman J, et al. Diagnostic Interview for Genetic Studies. Rationale, unique features, and training. NIMH Genetics Initiative. Archives of General Psychiatry. 1994;51(11):849–859(Discussion 863–844)
  23. Ophoff RA, Escamilla MA, Service SK, Spesny M, Meshi DB, Poon W, et al. Genomewide linkage disequilibrium mapping of severe bipolar disorder in a population isolate. American Journal of Human Genetics. 2002;71(3):565–574
  24. Ott J. Analysis of Human Genetic Linkage. Baltimore, MD: Johns Hopkins University Press; 1999;
  25. Park N, Juo SH, Cheng R, Liu J, Loth JE, Lilliston B, et al. Linkage analysis of psychosis in bipolar pedigrees suggests novel putative loci for bipolar disorder and shared susceptibility with schizophrenia. Molecular Psychiatry. 2004;9:1091–1099
  26. Patil N, Berno AJ, Hinds DA, Barrett WA, Doshi JM, Hacker CR, et al. Blocks of limited haplotype diversity revealed by high-resolution scanning of human chromosome 21. Science. 2001;294(5547):1719–1723
  27. Perneger TV. What's wrong with Bonferroni adjustments. British Medical Journal. 1998;316(7139):1236–1238
  28. Raux G, Bonnet-Brilhault F, Louchart S, Houy E, Gantier R, Levillain D, et al. The 2 bp deletion in exon 6 of the 'alpha 7-like' nicotinic receptor subunit gene is a risk factor for the P50 sensory gating deficit. Molecular Psychiatry. 2002;7(9):1006–1011
  29. Shytle RD, Silver AA, Lukas RJ, Newman MB, Sheehan DV, Sanberg PR. Nicotinic acetylcholine receptors as targets for antidepressants. Molecular Psychiatry. 2002;7(6):525–535
  30. Shytle RD, Silver AA, Sheehan KH, Sheehan DV, Sanberg PR. Neuronal nicotinic receptor inhibition for treating mood disorders: preliminary controlled evidence with mecamylamine. Depression and Anxiety. 2002;16(3):89–92
  31. Spielman RS, Ewens WJ. The TDT and other family-based tests for linkage disequilibrium and association. American Journal of Human Genetics. 1996;59(5):983–989
  32. Talib S, Okarma TB, Lebkowski JS. Differential expression of human nicotinic acetylcholine receptor alpha subunit variants in muscle and non-muscle tissues. Nucleic Acids Research. 1993;21(2):233–237
  33. Weiland S, Bertrand D, Leonard S. Neuronal nicotinic acetylcholine receptors: from the gene to the disease. Behavioural Brain Research. 2000;113(1–2):43–56
  34. Wood S, Schertzer M, Yaremko ML. Identification of the human neuronal nicotinic cholinergic alpha 2 receptor locus, (CHRNA2), within an 8p21 mapped locus, by sequence homology with rat DNA. Somatic Cell and Molecular Genetics. 1995;21(2):147–150
  35. Xu J, Pato MT, Torre CD, Medeiros H, Carvalho C, Basile VS, et al. Evidence for linkage disequilibrium between the alpha 7-nicotinic receptor gene (CHRNA7) locus and schizophrenia in Azorean families. American Journal of Medical Genetics. 2001;105(8):669–674
  36. Zapata C, Carollo C, Rodriguez S. Sampling variance and distribution of the D' measure of overall gametic disequilibrium between multiallelic loci. Annals of Human Genetics. 2001;65(Pt 4):395–406

PII: S0165-1781(05)00118-6

doi: 10.1016/j.psychres.2005.04.004

Psychiatry Research
Volume 135, Issue 3 , Pages 171-177 , 30 June 2005

Article Tools

* Image Usage & Resolution